The Latin American Epidemiology Network for ALS (Laenals)

References

• Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. Erratum in: Nat Rev Dis Primers. 3:17085.
   PubMed Web of Science ®Google Scholar
• van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084–98.
   PubMed Web of Science ®Google Scholar
• GBD 2016 Motor Neuron Disease Collaborators. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17:1083–97.
   PubMed Web of Science ®Google Scholar
• Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540–9.
   PubMed Web of Science ®Google Scholar
• Luna J, Logroscino G, Couratier P, Marin B. Current issues in ALS epidemiology: variation of ALS occurrence between populations and physical activity as a risk factor. Rev Neurol. 2017;173:244–53.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Valenzuela D, Zitko P, Lillo P. Amyotrophic lateral sclerosis mortality rates in Chile. A population-based study (1994-2010). Amyotroph Lateral Scler Frontotemporal Degener. 015;16:372–7.
   Google Scholar
• Bucheli M, Andino A, Montalvo M, Cruz J, Atassi N, Berry J, et al. Amyotrophic lateral sclerosis: analysis of ALS cases in a predominantly admixed population of Ecuador. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:106–13.
   PubMed Web of Science ®Google Scholar
• Mehta P, Raymond J, Punjani R, Larson T, Bove F, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Amyotroph Lateral Scler Frontotemporal Degener. 2021;23:1–6.
   PubMedGoogle Scholar
• Punjani R, Wagner L, Horton K, Kaye W. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:123–30.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Mehal JM, Holman RC, Rowland LP, Rowland AS, Cheek JE. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives. JAMA Neurol. 2013;70:476–80.
   PubMed Web of Science ®Google Scholar
• Roberts AL, Johnson NJ, Chen JT, Cudkowicz ME, Weisskopf MG. Race/ethnicity, socioeconomic status, and ALS mortality in the United States. Neurology 2016;87:2300–8.
   PubMed Web of Science ®Google Scholar
• Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron MC, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229–45.
   PubMed Web of Science ®Google Scholar
• Shahrizaila N, Sobue G, Kuwabara S, Kim SH, Birks C, Fan DS, et al. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J Neurol Neurosurg Psychiatry. 2016;87:821–30.
   PubMed Web of Science ®Google Scholar
• Erazo D, Luna J, Preux PM, Boumediene F, Couratier P. Epidemiological and genetic features of amyotrophic lateral sclerosis in Latin America and the Caribbean: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2021;:1–13. doi: 10.1080/21678421.2021.1909066. Online ahead of print.
   Web of Science ®Google Scholar
• Byrne S, Jordan I, Elamin M, Hardiman O. Age at onset of amyotrophic lateral sclerosis is proportional to life expectancy. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:604–7.
   PubMed Web of Science ®Google Scholar
• Ryan M, Zaldívar Vaillant T, McLaughlin RL, Doherty MA, Rooney J, Heverin M, et al. Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations. J Neurol Neurosurg Psychiatry. 2019;90:659–65.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;13:1108–13.
   PubMed Web of Science ®Google Scholar
• Chiò A, Mazzini L, D’Alfonso S, Corrado L, Canosa A, Moglia C, et al. The multistep hypothesis of ALS revisited: the role of genetic mutations. Neurology 2018;91:e635–42.
   PubMed Web of Science ®Google Scholar
• D’Ovidio F, Rooney JPK, Visser AE, Vermeulen RCH, Veldink JH, Van Den Berg LH, et al. Critical issues in ALS case-control studies: the case of the Euro-MOTOR study. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:411–8.
   PubMed Web of Science ®Google Scholar
• Gil J, Vazquez MC, Ketzoian C, Perna A, Marin B, Preux PM, Couratier P. Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population. Amyotroph Lateral Scler. 2009;10:355–60.
   PubMed Web of Science ®Google Scholar
• Vázquez MC, Ketzoián C, Legnani C, Rega I, Sánchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology 2008;30:105–11.
   PubMed Web of Science ®Google Scholar
• https://www.latinobarometro.org/lat.jsp Accessed December 10 2021
   Google Scholar
• Marcheco-Teruel B, Parra EJ, Fuentes-Smith E, Salas A, Buttenschøn HN, Demontis D, et al. Cuba: exploring the history of admixture and the genetic basis of pigmentation using autosomal and uniparental markers. PLoS Genet. 2014;10:e1004488.
   PubMed Web of Science ®Google Scholar
• Cabrera-Gómez JA, Kurtzke JF, González-Quevedo A, Lara-Rodríguez R. An epidemiological study of neuromyelitis optica in Cuba. J Neurol. 2009;256:35–44.
   PubMed Web of Science ®Google Scholar
• Sans M, Merriwether DA, Hidalgo PC, Bentancor N, Weimer TA, Franco MH, et al. Population structure and admixture in Cerro Largo, Uruguay, based on blood markers and mitochondrial DNA polymorphisms. Am J Hum Biol. 2006;18:513–24.
   PubMed Web of Science ®Google Scholar
• O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2.
   PubMed Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557–63.
   PubMed Web of Science ®Google Scholar
• Rooney JPK, Brayne C, Tobin K, Logroscino G, Glymour MM, Hardiman O. Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurology 2017;88:2321–9.
   PubMed Web of Science ®Google Scholar